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Abstract Mutations arise during DNA replication
due to oxidative lesions and intrinsic polymerase
errors. Mitochondrial DNA (mtDNA) mutation rate is
therefore closely linked to the mitochondrial DNA
turnover process, especially in post mitotic cells. This
makes the mitochondrial DNA turnover rate critical
for understanding the origin and dynamics of mtDNA
mutagenesis in post mitotic cells. Experimental mito-
chondrial turnover quantification has been based on
different mitochondrial macromolecules, such as mito-
chondrial proteins, lipids and DNA, and the experimental
data suggested highly divergent turnover rates, ranging
from over 2 days to about 1 year. In this article we argue
that mtDNA turnover rate cannot be as fast as is often
envisaged. Using a stochastic model based on the
chemical master equation, we show that a turnover rate
corresponding to mtDNA half-life in the order of months
is the most consistent with published mtDNA mutation
levels.
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Mitochondrial and mitochondrial DNA turnover
Accumulation of mitochondrial DNA (mtDNA) muta-
tions and mitochondrial dysfunction are often sug-
gested to be important mechanisms of ageing (Harman
1972). Since mutations predominantly occur during
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mtDNA replication, either as a consequence of
oxidative lesions or of intrinsic polymerase errors
(Kujoth et al. 2007), mtDNA turnover rate is a critical
parameter determining de novo mtDNA mutation rate
(Poovathingal et al. 2009). The mtDNA turnover rate
may also impact clonal expansion dynamics of
mtDNA mutations (Chinnery and Samuels 1999;
Nicholas et al. 2009; Poovathingal et al. 2009). In
post-mitotic tissues, mtDNA turnover is often consid-
ered to be mainly associated with the biogenesis of
mitochondria that balances the mitochondrial autoph-
agy (mitophagy) process, where the complete orga-
nelle and its constituents are catabolized by cellular
double membrane structures known as autophago-
somes (Nakatogawa et al. 2009). However, mitochon-
dria do not generally exist as disconnected organelles,
but undergo rapid fusion and fission, forming large,
complex reticular structures (Chen and Chan 2005).
Therefore, it is not trivial to define what exactly
constitutes the ‘‘turnover of a mitochondrion’’.
Despite of this, mitochondrial turnover rates have
been proposed based on the turnover rates of various
mitochondrial constituents such as mitochondrial
proteins (Lipsky and Pedersen 1981; Menzies and
Gold 1971; Miwa et al. 2008), mtDNA (Collins et al.
2003; Gross et al. 1969; Korr et al. 1998) or lipids
(cardiolipin) (Fletcher and Sanadi 1961; Gross et al.
1969; Huemer et al. 1971).
Experimental data on the turnover of mitochondrial
components are limited and divergent. Reported half-
lives range from *2 to 350 days, depending on
reference molecules and measurement techniques
(Collins et al. 2003; Gross et al. 1969; Huemer et al.
1971; Korr et al. 1998; Miwa et al. 2008). Half-life
values of about 2–17 days, derived from bulk protein
turnover data, are often cited as the global mitochon-
drial turnover rate (Fletcher and Sanadi 1961; Menzies
and Gold 1971; Miwa et al. 2008). However, as argued
above, it is unclear if a global mitochondrial turnover
can in fact be meaningfully defined. Importantly, if
these short half-life values are assumed to be indic-
ative of the mtDNA turnover rate, they would have
dramatic impact on age-dependent mtDNA mutation
accumulation dynamics (Chinnery and Samuels 1999;
Elson et al. 2001; Kowald et al. 2005; Kowald and
Kirkwood 2000; Poovathingal et al. 2009). It is the
latter relationship that we will explore in more detail
below.
Challenges with estimating global mitochondrial
turnover rate—implications in estimating mtDNA
turnover rate
Mitochondrial protein turnover rates are commonly
used as a proxy for the turnover of the complete
mitochondrial organelle (Fletcher and Sanadi 1961;
Miwa et al. 2008) and thus for mtDNA turnover.
Mitochondrial protein turnover rates are usually
measured using pulse chase experiments (Fletcher
and Sanadi 1961; Menzies and Gold 1971; Miwa et al.
2008). In these experiments, isotope-labeled protein
precursor molecules are administered, followed by
tracking the labeled mitochondrial protein. The first-
order decay rate for the loss of isotope-label yields
mitochondrial protein half-lives. However, such data
must be interpreted with caution when extending this
to estimate turnover rate of other mitochondrial
components. For one, mitochondria contain *1,200
different polypeptides (Mootha et al. 2003), with
reported half-lives ranging from a little over an hour to
more than 10 days (Table 1). The presence of intra-
mitochondrial proteolytic systems (Mijaljica et al.
2007) implies that mitochondrial proteins can be
degraded independent of organelle turnover, resulting
in protein-specific half-lives (Jaleel et al. 2008). In
contrast to proteomics approaches, pulse chase exper-
iments utilizing bulk protein will thus result in half-
lives that reflect the average turnover of the population
of proteins in mitochondria (Miwa et al. 2008).
Therefore, protein turnover data from such experi-
ments may be dominated by the turnover rate of few
abundant proteins. This suggests that, even with the
best experimental practices and even when artifacts,
such as precursor reutilization (Burgess et al. 1978;
Lipsky and Pedersen 1981; Miwa et al. 2008), are
carefully controlled, bulk protein turnover might still
overestimate the turnover of mitochondrial compo-
nents, such as mtDNA.
Individual mitochondrial protein half-lives of more
than 10 days have been reported (Table 1). If these
experimental data are accepted, mitochondrial half-
life, if meaningful at all, cannot be shorter than
10 days. However, more data from mitochondrial
proteomics studies using modern methods would be
desirable [e.g.:(Dai et al. 2009)]. Long half-lives have
also been reported for other macromolecules in
mitochondria. For instance, a half-life of 40 days has
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been reported for the mitochondrial lipid cardiolipin
(Huemer et al. 1971). In this work, we are mainly
concerned with the turnover of mtDNA. Importantly,
attempts at direct measurement of mtDNA turnover
have yielded half-life values ranging from 10 days up
to as high as 300 days, again depending on tissue types
and experimental techniques (Collins et al. 2003;
Gross et al. 1969; Korr et al. 1998). However, even the
fastest reported mtDNA turnover rate (10 days)
(Gross et al. 1969) is significantly longer than the
two-day mitochondrial turnover rate estimated based
on the bulk protein measurements (Miwa et al. 2008).
Physiological levels of mtDNA turnover rate—
mtDNA mutation data
The turnover rate of mtDNA critically determines how
fast de novo mtDNA mutations can occur, as each
replication event has a finite probability of introducing
a new mutation (Poovathingal et al. 2009). For the
purpose of this study, we considered age-related
mtDNA point mutations in a TaqI recognition site
(bp 634–637) in mouse heart tissues as reported by
Vermulst et al. (2007). The majority of these muta-
tions (86 %) are GC to AT transitions and for the TaqI
site investigated by Vermulst et al. (2007), such
mutations are silent, causing no change in amino acid
sequence of the relevant gene product and therefore
cannot be subjected to selective degradation. Further-
more, even for those mutations that are not silent, the
reported burdens are several orders of magnitude
lower than the levels that have been shown to affect
the electron transport chain (ETC). function (Inoue
et al. 2000; Vermulst et al. 2007). If these low levels of
mtDNA mutation burden are considered to be true,
then these data provide a constraint on the magnitude
of the mtDNA turnover rate, because ultimately
mtDNA turnover directly affects the observed de
novo mtDNA point mutation rate.
Using in silico simulations of random mtDNA
turnover and de novo mutations, we argue that mtDNA
turnover cannot be as rapid as is often envisaged based
on the mitochondrial protein turnover data. A sto-
chastic model based on chemical master equation
(CME) (Poovathingal et al. 2009) was used to simulate
the mitochondrial DNA turnover process and mtDNA
mutagenesis process at different mtDNA turnover
rates in cells. Using this stochastic model, we have
simulated the accumulation of mtDNA point muta-
tions burden in mouse heart tissue for several reported
mitochondrial turnover rates and then compared the
simulated burdens against the reported data.
In an earlier work (Poovathingal et al. 2009), we
have demonstrated that the faster turnover promotes
more rapid accumulation of mtDNA mutations. Here
this model has been used to investigate the constraint
on possible mtDNA turnover rate, given the observed
mtDNA point mutation burden. We apply this model
to the cases of wild-type and polymerase-c (POLG)
mutator mice, for which mtDNA point mutation data
have been previously reported (Vermulst et al. 2007).
The in silico mtDNA model tracks the accumulation of
point mutations in cardiomyocytes (2.5 9 107 cells)
during two stages of life: development and post-
development (Fig. S1 in Online Resource 1). In the
model, we assumed that the mtDNA population in
each cell consists of only wild-type (W) and mutant
Table 1 Turnover rates of some mammalian mitochondrial proteins
S. no. Protein Half life Organism/tissue Reference
1 Ornithine aminotransferase 1.9 days Rat liver Ip et al. (1974)
2 Cytochrome oxidase 5.7 Rat liver Ip et al. (1974)
3 Carbamyl phosphate synthetase 7.7 Rat Nicoletti et al. (1977)
4 Malate dehydrogenase 2.6 Rat Nicoletti et al. (1977)
5 Aminolevulinate synthetase 70 min Rat liver Marver et al. (1966)
6 Cytochrome c 10.3 days Rat liver Fletcher and Sanadi (1961)
7 Ornithine transcarbamylase 7.7 days Rat liver Wallace et al. (1986)
8 Cytochrome c 11.8 days Rabbit heart Grozdova and Starostina (1973)
9 66 different mitochondrial proteins 2–8.5 days Rat skeletal muscle Jaleel et al. (2008)
10 Various *18–95 days Rat brain Rodrijguez de Lores et al. (1971)
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(M) molecules and that these mtDNA are well-mixed
due to fast fusion-fission (Chinnery and Samuels 1999;
Poovathingal et al. 2009). The stochastic model was
formulated as a CME that describes the random
mtDNA turnover process, comprising of relaxed
replication and degradation of mtDNA (details in
the Online Resource 1). Importantly, mutant and
wild-type mtDNA are equally likely to replicated or
degraded during mtDNA turnover. De novo point
mutations are assumed to result from mtDNA repli-
cation errors due to two cumulative factors: oxida-
tive lesions associated with ROS and the finite
fidelity of the mtDNA polymerase-c (POLG) enzyme
(Kunkel 1992; Zhang et al. 2000) (Fig. S2 in Online
Resource 1).
Oxidative lesions in mtDNA, including but not
limited to 8OHdG, one of the oxidation products of
guanine, facilitate the formation of point mutations
during mtDNA replication because of alternative
hydrogen bonding configuration of the oxidized bases
leading to inappropriate base-paring. Therefore, the
presence of oxidative lesions such as 8OHdG during
mtDNA replication is an important determinant of
mutation probability during replication. Essentially,
mtDNA replication can turn oxidative lesions in the
template strand (oxidative damage) into point muta-
tions in the newly synthesized strand (Halliwell and
Aruoma 1991; Halliwell and Gutteridge 1999). It is
extremely challenging to accurately determine the rate
of de novo oxidative damage events and of repair of
such damage in vivo. The most widely available
parameter related to oxidative DNA damage is there-
fore the steady state damage level of various oxidative
DNA lesions, including 8OHdG. Steady state damage
level results from the balance between the damage rate
and repair rate. At any given time, there is a small
fraction of the total damage events that remain
unrepaired. Such steady state damage levels are
typically very low, representing only a tiny fraction
of the damage events that occur.
In vivo 8OHdG burden in nuclear DNA has been
reported to be between 0.3 and 4.2 lesions per 106 bp
based on different samples and different measurement
techniques (ESCODD 2002a, b). However, such
lesions make up only about 10–20 % of the complete
damage spectra (Halliwell and Aruoma 1991; Halli-
well and Gutteridge 1999) and thus, the overall
oxidative lesions could range between 1.5 and 4.2
lesions per 106 bp. In our model simulations, we have
made a conservative assumption that the oxidative
damage to mtDNA is the same as that to nuclear DNA
and have also used the lowest value in the range
(1.5 9 10-6 bp-1). This means that our model simu-
lations likely underestimate the overall mutation rate
during mtDNA replication. Importantly, oxidative
lesions are converted into mutations only when
mtDNA is replicated.
On the other hand, the reported POLG fidelity
values range from 10-7 to 10-4 mutations bp-1
replication-1, depending on cell types and quantifica-
tion assays (Johnson and Johnson 2001; Kunkel 1985;
Kunkel et al. 1987; Lee and Johnson 2006). In the
simulations of the POLG transgenic mice, the repli-
cation error frequency due to POLG fidelity was set to
200 times higher than that of the wild-type mouse,
based on the commonly reported literature data
(Kunkel 1992; Zhang et al. 2000). Again, we have
used the most conservative (lowest) values from the
above range when computing the frequency of
mtDNA replication error. Thus the mutation burden
obtained by our model simulations should represent a
lower limit (more details in Online Resource 1).
Many mitochondrial related processes were left out
from the model, such as selective degradation of
mitochondria with lower membrane potential (possi-
bly due to mitochondria harboring high levels of
detrimental mtDNA mutations) (Kim et al. 2007) and
retrograde signaling (Liu and Butow 2006). While each
of these processes may complicate or mask the
inference of mtDNA turnover rate, we note that such
processes are relevant only when mtDNA mutations
become physically detectable, for instance through
effects on the ETC activity, ATP or ROS levels or
through impact on mitochondrial membrane potential
(Kanki and Klionsky 2008; Narendra et al. 2008; Twig
et al. 2008). Obviously, for highly deleterious mtDNA
mutations, selective degradation of the affected mito-
chondria could serve as their clearance mechanism and
by ignoring this process, our model simulation analysis
may suggest an artificially slow mtDNA turnover rate.
On the other hand, if retrograde signaling was prom-
inent, the mtDNA turnover rate predicted by our basic
model would be an exaggeration.
Mutant mtDNA carrying a single point mutation is
indistinguishable from WT DNA unless the mutation
causes some sort of phenotypes. Meanwhile, the
mechanisms proposed for selective degradation and
retrograde signaling assume functionally relevant
560 Biogerontology (2012) 13:557–564
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mutations (that is, mutations causing mitochondrial
deficiency). This means that, while it is possible that
such mechanisms operate to control the accumulation
of some detrimental mutations such as mtDNA
deletions or pathological point mutations, they cannot
impact the accumulation of mutations that have no
functional effect on mitochondria. In particular,
selective degradation and retrograde signaling cannot
impact the accumulation of silent point mutations. The
stochastic drift of these mutations should arise only
from mtDNA turnover, which was captured in our
basic model as stated above. Such a simple model has
other benefits, for example only a few model param-
eters need to be specified. In this case, the model
involves only two free parameters, which are the
mtDNA copy number at steady state and the de novo
mutation frequency. The remaining model parameter
is associated with the half-life of mtDNA. Therefore,
model simulations reflected a direct causal relation-
ship between mtDNA turnover and mutation burden.
Simulations of the model in this work were
performed to predict the accumulation of mtDNA
point mutations in post mitotic heart tissue of wild-
type and POLG mutator mice. The steady state
mtDNA copy number was set based on the reported
value for mouse heart tissue (see supporting informa-
tion in Online Resource 1), from which the mtDNA
mutation burden were measured (Vermulst et al.
2007). Finally, model simulations were carried out
using modified Gillespie’s algorithm (see Online
Resource 1, online for more details) and the complete
model parameters used are included in the Online
Resource 2, 3 and 4.
We have compared the mtDNA point mutation
burden data from wild-type (WT) and POLG mutator
mice (Vermulst et al. 2007) with those predicted by
model simulations above with different mtDNA
turnover rates, as shown in Fig. 1. The modeling
results clearly show that, as long as neither mutant nor
wild-type mtDNA are preferentially degraded or
replicated, higher turnover rates always result in
increased mtDNA mutation burden. This is not
surprising, since de novo mtDNA mutations are tied
to mtDNA replication. Note that we have explicitly
made conservative assumptions regarding the occur-
rence of de novo mutations in this model, by setting
the error rate arising due to limited POLG fidelity and
lesions arising due to oxidative damage to the lowest
plausible values that are consistent with the literature.
Figure 1d shows that the mtDNA mutation burden
obtained using a short mitochondrial half-life
[*2 days (Miwa et al. 2008)] does not fit well with
the point mutation burden experimental data (Ver-
mulst et al. 2007). Simulations using other reported
half-lives, ranging from 10 to 300 days (Collins et al.
2003; Gross et al. 1969; Korr et al. 1998; Menzies and
Gold 1971) as shown in Fig. 1a–c, indicate that the
observed mtDNA mutation burden data for both the
WT and POLG mice are most consistent with a
mtDNA turnover rate corresponding to a half-life
between 30 and 300 days. However, as we have taken
a conservative assumption regarding the frequency of
de novo mutations in this model, the actual mtDNA
turnover rate could even be slower.
A slow mtDNA turnover rate during aging implies
that de novo somatic mtDNA mutations are rare events.
As we have discussed elsewhere (Poovathingal et al.
2009), for 300 day mtDNA half-life, the number of de
novo mutations during the developmental stage of mice
(where mtDNA replication frequency is tied to cell
divisions) is roughly equal to that during the entire adult
life of the organisms. In simulations, each somatic cell
experiences on average between 2 and 3 de novo
mutations during 3 years of mouse lifespan. Therefore,
most mtDNA mutations may already exist in early life,
consistent with findings from a deep sequencing study
(Ameur et al. 2011). Also, these single mutational
events would become the starting point for the (random)
accumulation of mtDNA mutations during aging, a
process known clonal expansion (Larsson 2011). An
increase in either mtDNA turnover rate or replication
error rate (e.g. due to increased oxidative lesions) would
mean a higher de novo mtDNA mutation frequency. A
more detailed exposition on the relationship between
mtDNA turnover and age-related mtDNA mutation
dynamics has also been given in an earlier work
(Poovathingal et al. 2009).
Concluding remarks
Attributing a global mitochondrial half-life parameter
based on the turnover of any individual mitochondrial
components requires strong justification and given the
dynamic characteristics of mitochondria, the very
concept of ‘‘whole organelle’’ turnover may be
questionable. We believe that there are strong argu-
ments for mtDNA half-lives to be longer than a month.
Biogerontology (2012) 13:557–564 561
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If a global organelle turnover parameter were to be at
all meaningful, it would have to be much slower than
commonly quoted mitochondrial turnover time of
2–10 days (Gross et al. 1969; Miwa et al. 2008).
Interestingly, there are several studies reporting longer
half-lives ([30 days) for cardiolipin, mtDNA and
some individual proteins. As shown here, support for
slow turnover of mtDNA comes from the quantifica-
tion of age-related mtDNA mutations. Using a
stochastic computational model based on minimal
and conservative assumptions regarding the mtDNA
turnover process and the associated de novo muta-
genesis, we found that simulations using a short
mtDNA half-life of 2 days grossly overestimate
mtDNA point mutations when compared with pub-
lished data for mutation burden (Vermulst et al. 2007).
The available experimental data were most consistent
with a mtDNA half-life of months. In parallel to our
conclusion, a previous computational study suggested
that mitochondrial deoxyribonucleoside salvage path-
way alone could not support a rapid mtDNA replica-
tion (*2 h mtDNA) and that the kinetics of this
pathway could only provide for a much slower
mtDNA replication of longer than 10 h (Gandhi and
Samuels 2011).
The rate of mtDNA turnover is a crucial parameter,
determining the rates of de novo mutations and the
consequent age-dependent loss of mtDNA integrity
a b
c d
Fig. 1 Comparison of experimental data and simulations of
point mutation frequency in wild-type and POLG mice (n = 10)
(Vermulst et al. 2007) for different values of mtDNA turnover
rate. The frequencies of the accumulated point mutations in
mouse heart at the end of 29 months for wild-type mouse and at
the end of 6 months of age for POLG?/mut and POLGmut/mut
mice. Please note that the mutation frequency coordinate is in
log-scale. Results of point mutation frequencies are obtained
using mtDNA turnover rates of a. t1=2 ¼ 2 days, (Miwa et al.
2008) b. t1=2 ¼ 10 days, (Gross et al. 1969) c. t1=2 ¼ 30 days,
(Gross et al. 1969) and d. t1=2 ¼ 300 days (Collins et al. 2003)
562 Biogerontology (2012) 13:557–564
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and mitochondrial function (Gruber et al. 2008;
Poovathingal et al. 2009; Wiesner et al. 2006). Given
the fundamental role of mtDNA turnover rate for the
understanding of the basic mechanism(s) of ageing,
we feel that the accurate quantification of this rate is an
important issue worthy of further careful experimental
studies, if possible, by a direct and sensitive experi-
mental estimation of mtDNA turnover. While some
components of mitochondria are turned over rapidly,
the global mitochondrial turnover rate, if meaningful
at all, could not be faster than that of the most
persistent macromolecules, e.g. mtDNA. Certainly,
bulk protein turnover rate should not be used as a
surrogate for mtDNA turnover.
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